Cargando…

Inhibition of pathological brain angiogenesis through systemic delivery of AAV vector expressing soluble FLT1

The soluble vascular endothelial growth factor (VEGF) receptor 1 (sFLT1) has been tested in both animals and humans for anti-angiogenic therapies, e.g., age-related macular degeneration. We hypothesized that adeno-associated viral vector (AAV)-mediated sFLT1 expression could be used to inhibit abnor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Fanxia, Mao, Lei, Zhu, Wan, Lawton, Michael T., Pechan, Peter, Colosi, Peter, Wu, Zhijian, Scaria, Abraham, Su, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636448/ https://www.ncbi.nlm.nih.gov/pubmed/26090874 http://dx.doi.org/10.1038/gt.2015.57

Ejemplares similares

Aurintricarboxylic acid increases yield of HSV-1 vectors
por: Pechan, Peter, et al.
Publicado: (2014)

Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis
por: Ahmad, Shakil, et al.
Publicado: (2011)

Universal Method for the Purification of Recombinant AAV Vectors of Differing Serotypes
por: Nass, Shelley A., et al.
Publicado: (2017)

Effective delivery of large genes to the retina by dual AAV vectors
por: Trapani, Ivana, et al.
Publicado: (2014)

Ocular and systemic safety of a recombinant AAV8 vector for X-linked retinoschisis gene therapy: GLP studies in rabbits and Rs1-KO mice
por: Marangoni, Dario, et al.
Publicado: (2016)

T Cell-Mediated Immune Responses to AAV and AAV Vectors
por: Ertl, Hildegund C. J.
Publicado: (2021)

Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye
por: Li, Wensheng, et al.
Publicado: (2009)

Engineered AAV vectors for improved central nervous system gene delivery
por: A Kotterman, Melissa, et al.
Publicado: (2015)

Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors
por: Reul, Johanna, et al.
Publicado: (2019)

AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6
por: Denard, Jérôme, et al.
Publicado: (2018)

Global brain delivery of neprilysin gene by intravascular administration of AAV vector in mice
por: Iwata, Nobuhisa, et al.
Publicado: (2013)

AAV Vector-Mediated Antibody Delivery (A-MAD) in the Central Nervous System
por: Marino, Marika, et al.
Publicado: (2022)

Soluble Flt-1 in AMI Patients Serum Inhibits Angiogenesis of Endothelial Progenitor Cells by Suppressing Akt and Erk’s Activity
por: Zhang, Lijie, et al.
Publicado: (2022)

Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors
por: Wang, Qizhao, et al.
Publicado: (2016)

Proteosomal Degradation Impairs Transcytosis of AAV vectors from Suprachoroidal Space to Retina
por: Ding, Kun, et al.
Publicado: (2021)

Targeting Photoreceptors via Intravitreal Delivery Using Novel, Capsid-Mutated AAV Vectors
por: Kay, Christine N., et al.
Publicado: (2013)

Gene Delivery to Adipose Tissue Using Transcriptionally Targeted rAAV8 Vectors
por: Uhrig-Schmidt, Silke, et al.
Publicado: (2014)

AAV vectors engineered to target insulin receptor greatly enhance intramuscular gene delivery
por: Jackson, Cody B., et al.
Publicado: (2020)

Innate Immune Responses to AAV Vectors
por: Rogers, Geoffrey L., et al.
Publicado: (2011)

AAV Vectored Immunoprophylaxis for Filovirus Infections
por: Rghei, Amira D., et al.
Publicado: (2020)

AAV gene therapy vectors in the TMJ
por: Brouxhon, Sabine M., et al.
Publicado: (2022)

Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor
por: Miralles, Marta, et al.
Publicado: (2017)

Targeting the somatosensory system with AAV9 and AAV2retro viral vectors
por: Skorput, Alexander G. J., et al.
Publicado: (2022)

Neonatal AAV delivery of alpha-synuclein induces pathology in the adult mouse brain
por: Delenclos, Marion, et al.
Publicado: (2017)

Preclinical evaluation of FLT190, a liver-directed AAV gene therapy for Fabry disease
por: Jeyakumar, Jey M., et al.
Publicado: (2023)

Anti-angiogenesis gene therapy for hepatocellular carcinoma via systemic injection of mesenchymal stem cells engineered to secrete soluble Flt-1
por: Li, Guanglin, et al.
Publicado: (2017)

Correction: Targeting Photoreceptors via Intravitreal Delivery Using Novel, Capsid-Mutated AAV Vectors
Publicado: (2014)

Correction: Targeting Photoreceptors via Intravitreal Delivery Using Novel, Capsid-Mutated AAV Vectors
por: Kay, Christine N., et al.
Publicado: (2013)

Systemic Delivery of Tyrosine-Mutant AAV Vectors Results in Robust Transduction of Neurons in Adult Mice
por: Iida, Asako, et al.
Publicado: (2013)

Kinetics and MR-Based Monitoring of AAV9 Vector Delivery into Cerebrospinal Fluid of Nonhuman Primates
por: Ohno, Kousaku, et al.
Publicado: (2018)

AAV-Containing Exosomes as a Novel Vector for Improved Gene Delivery to Lung Cancer Cells
por: Liu, Bin, et al.
Publicado: (2021)

Stent-based delivery of AAV2 vectors encoding oxidation-resistant apoA1
por: Hooshdaran, Bahman, et al.
Publicado: (2022)

Near-perfect infectivity of wild-type AAV as benchmark for infectivity of recombinant AAV vectors
por: Zeltner, Nadja, et al.
Publicado: (2010)

Successful Transduction with AAV Vectors after Selective Depletion of Anti-AAV Antibodies by Immunoadsorption
por: Orlowski, Alejandro, et al.
Publicado: (2020)

Soluble Flt-1 Gene Delivery in Acute Myeloid Leukemic Cells Mediating a Nonviral Gene Carrier
por: Amini, Razieh, et al.
Publicado: (2013)

AAV Vectors Vaccines Against Infectious Diseases
por: Nieto, Karen, et al.
Publicado: (2014)

AAV vector-mediated in vivo reprogramming into pluripotency
por: Senís, Elena, et al.
Publicado: (2018)

A Novel Retinal Ganglion Cell Promoter for Utility in AAV Vectors
por: Hanlon, Killian S., et al.
Publicado: (2017)

Mapping the AAV Capsid Host Antibody Response toward the Development of Second Generation Gene Delivery Vectors
por: Tseng, Yu-Shan, et al.
Publicado: (2014)

Alginate hydrogel polymers enable efficient delivery of a vascular-targeted AAV vector into aortic tissue
por: Remes, Anca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g8ut8rna4iapek4dnl2oa7k2h4